Thank you, Fabrizio, and hello, everyone. Our third quarter organic net sales declined 8% and earnings per share decreased 75% to $0.47. As Fabrizio mentioned despite continued challenges in our Asia travel retail business, we experienced accelerated growth across our markets globally with nearly every market expanding as they progressed through various stages of recovery from the pandemic. From a geographic standpoint, organic net sales in our Asia-Pacific region rose 7% with nearly all markets contributing led by Hong Kong which doubled in size partially due to the return of Chinese traveler while Australia grew nearly 50% and Japan rose double-digits, Mainland China also returned to growth this quarter, showing positive signs of recovery in February and March, after the pressure from the increase in COVID cases, and slower retail traffic in January. Throughout the regions, markets continue to progress and recovery with fewer COVID restrictions compared to last year, leading to growth in all product categories, with the return of brick-and-mortar traffic. Strong double-digit growth from the regions in emerging markets contributed one point to Asia-Pacific's growth. Organic net sales in the Americas grew 6%, lead by the United States. In North America, organic net sales grew mid single-digits, reflecting growth in skincare, makeup, and fragrance. The Ordinary, M·A·C, and Le Labo excelled, each rising double-digits in the quarter. Specialty multi-growth including distribution expansion drove the increase in brick-and-mortar along with contributions from freestanding stores and department stores. In Latin America, organic net sales grew double-digits, benefiting from growth in every country and in all product categories with particular strength in makeup and fragrance. Organic net sales in our Europe, the Middle East, and Africa regions fell 24%, driven entirely by the travel retail business. Our global travel retail sales continue to be pressured by our Asia travel retail business, which Fabrizio described. Outside of Asia, we experienced double-digit sales growth in travel retail, as international travel increased throughout Europe, and the Americas. The overall performance in travel retail more than offset the organic net sales growth from the rest of the EMEA region, where we drove strong performance in all product categories and from nearly all channels of distribution. Organic net sales rose across both developed and emerging markets, lead by the United Kingdom, Germany, France, Italy, and Turkey, as the progression to recovery continued, and tourism resumed. From a category standpoint, fragrance continued its momentum as organic net sales rose 14%. Strong demand for our products and high-touch services as well as innovation fueled growth across every geographic region. TOM FORD Beauty, Le Labo, and Estée Lauder each grew double-digits in the quarter. Organic net sales in hair care grew 3%, and sales were virtually flat in makeup. Makeup growth in the Americas, Asia-Pacific, and the markets in EMEA, excluding travel retail was offset by the pressures in Asia travel retail. M·A·C and Clinique continue to drive makeup recovery, and double-digit growth from TOM FORD Beauty and Too Faced also contributed. Nearly every market in Asia-Pacific realized strong growth in the category, partially offset by softness in Mainland China. Organic net sales in skincare fell 17%, due to the pressures affecting Asia travel retail. The declines from La Mer and Estée Lauder were partially offset by standout performance from The Ordinary and M·A·C. The Ordinary benefited from strong growth in specialty multi-channel, particularly in the U.S., as well as from geographic expansion into India and the Middle East this year, as well as the success of new product innovation. The launch of M·A·C hyper-real product franchise expanded its offering in the category, and contributed to growth. Our gross margin declined 750 basis points compared to last year, largely due to the slower-than-expected recovery in Asia travel retail. This includes obsolescence charges, higher promotional costs, and gets that to drive increased consumption, excess overhead absorption in our plants due to the pull down of production throughout the year, given higher inventory levels, and less favorable brand and category mix. Operating expenses increased 570 basis points as a percent of sales, driven largely by the reduction in sales. We continued our investments to support recovery markets in areas such as advertising, promotional activities, and innovation, which collectively increased 230 basis points, compared to last year. Operating income declined 66% to $360 million, and our operating margin contracted 1,320 basis points to 8.4% in the quarter. Despite the volatility that has significantly impacted net sales we have sustained certain of our strategic investments to support recovery in select markets, and the strengthening of our multiple engines of growth. We continue to invest in areas inherited to long-term profitable growth, including innovation, advertising, the growth of our emerging markets, the geographic expansion of some of our brands, production capacity, and consumer engagement. Our effective tax rate for the quarter was 43.1%, compared to 21.3% last year. The increase in rate was primarily due to the expected further reduction in earnings, related to our travel retail business for fiscal 2023. Diluted EPS of $0.47 decreased 75% compared to last year. This was at the high-end of our outlook, despite the significantly higher-than-normal tax rate. The impact from foreign currency translation and foreign currency transactions in key travel retail locations negatively impacted diluted EPS by 1%, and 3% respectively. For the nine months, we generated $1 billion in net cash flows from operating activity, compared to $2 billion last year. The decline from last year reflects lower net income, partially offset by lower working capital. We invested $652 million in capital expenditures, and we returned $945 million in cash to stockholders through both dividends and share repurchases. On April 28, we were pleased to complete the acquisition of the TOM FORD brand. The amounts paid at closing of approximately $2.25 billion were funded through a combination of cash, including the proceeds from the issuance of commercial paper, and $250 million received from one of the licensees of the brand, Marcolin. An additional aggregate amount of $300 million in deferred payments and 5% interest per annum to the sellers become due from the company, beginning in July, 2025. We estimate an EPS dilution to the full-year of approximately $0.03 to $0.04. And now turning to our outlook for fiscal 2023, clearly this fiscal year has proven to be a perfect storm of higher-than-anticipated volatility, from both global, external headwinds and uncertainties surrounding the timing and pace of recovery from the COVID-19 pandemic, primarily in China and Asia travel retail. In August, we expected a gradual improvement throughout the first-half of the fiscal year, as markets in international travel began to recover from the impacts of COVID restrictions. However, the actual impacts to our business in Asia travel retail and China to a lesser extent have been far greater than we anticipated, given the prolonged challenges from the pandemic, including a slower-than-expected recovery of traffic and sales conversion in prestige beauty in these markets. Further compounding this pressure is the tightening of inventory by retailers in Hainan. We now expect that a far more gradual return to normal sales growth in Asia travel retail is likely to persist into the first-half of fiscal 2024. In addition, higher inflation and currency volatility as well as promotions in certain markets to alleviate high stock levels more than offset our price increases, and further pressured our business margins. In sight of the volatility in Asia travel retail that delayed the recovery relative to what we had expected, as well as the macro pressures from inflation and currency, we have been encouraged by the faster-than-anticipated improvements across many of our markets globally, as they progress through various stages of recovery from the pandemic. While we are lowering our full-year outlook to reflect continued decline in net sales in Asia travel retail, including the tightening of inventory by certain retailers, we plan to invest in markets where traffic and consumption are returning, and expect to return to overall net sales growth in the fourth quarter. This reflects double-digit sales growth in the Asia-Pacific region, including Mainland China, as well as in EMEA, excluding Asia travel retail. The Americas has planned to grow single-digits. Currency also continues to pressure margins relative to prior year. As Fabrizio mentioned, we are certainly not satisfied with our results this fiscal year, and will address plans to progressively rebuild the margin accretive areas of our business beyond this fiscal year from the current year's level. When full recovery does occur from the pandemic, we do expect the return to healthy growth of our Asia travel retail business, and in our related skincare category supported by a more normalized level of investment in selling, advertising and promotional activities, reflective of the increased brick-and-mortar traffic. With these assumptions as our backdrop and using March 31st spot rate of 1.09 for the euro, 1.239 for the pound, 6.872 for the yuan, and 12.97 for the Korean won, we now forecast organic net sales for the full-year to decline 75%. Currency translation is expected to dilute reported sales growth for the full fiscal year by 4 percentage points. And we anticipate an additional 1 point of dilution from the impact of certain foreign currency transactions and key international travel retail locations. The impact of sales from certain designer license access is expected to dilute reported growth by approximately 1 point. Full-year operating margin is forecasted to be approximately 11.1%. An 860 basis point contraction from the prior year period, primarily due to the disruptions from COVID restrictions that not only impacted sales in Asia travel retail and Mainland China but also resulted in increased obsolescence charges, discounts and promotional expenses. Foreign currency impact and the strategic investments, I mentioned previously. are also expected to pressure margin. We now expect our full-year effective tax rate to be approximately 27%, reflecting the change in our estimated geographical mix of earnings for the balance of the year. Diluted EPS is expected to range between $3.29 and $3.39 before restructuring and other charges. And, includes the expected impact of the Tom Ford acquisition I mentioned previously. This includes approximately $0.26 of dilution from currency translation. In constant currency, we expect EPS to decline approximately 51% which includes a negative impact from foreign currency transactions in key international travel retail location of approximately four percentage points. While this has been a challenging and disappointing year, navigating through many uncertainties the strength we are seeing in many of our recovery market gives us tremendous optimism for the future. Our long-term fundamentals and strategy remain intact as does our confidence in the long-term growth opportunity for global prestige beauty in our brands with the investments we have made to sustain long-term profitable growth. On behalf of Fabrizio and the Estée Lauder company's leadership team, we want to extend our immense gratitude to all of our employees around the world. We recognize that this has been an incredibly challenging year for you. And we want to thank you for your extraordinary efforts through dedication and commitment to the company and your resilience as we continue together on our path to recovery. And that concludes our prepared remarks. We will be happy to take your questions at this time.